Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence

Background Maintenance treatments are effective in retaining patients in treatment and suppressing heroin use. Questions remain regarding the efficacy of additional psychosocial services. Objectives To evaluate the effectiveness of any psychosocial plus any agonist maintenance treatment versus stand...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cochrane database of systematic reviews 2011-10, Vol.2011 (10), p.CD004147-CD004147
Hauptverfasser: Amato, Laura, Minozzi, Silvia, Davoli, Marina, Vecchi, Simona
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page CD004147
container_issue 10
container_start_page CD004147
container_title Cochrane database of systematic reviews
container_volume 2011
creator Amato, Laura
Minozzi, Silvia
Davoli, Marina
Vecchi, Simona
Amato, Laura
description Background Maintenance treatments are effective in retaining patients in treatment and suppressing heroin use. Questions remain regarding the efficacy of additional psychosocial services. Objectives To evaluate the effectiveness of any psychosocial plus any agonist maintenance treatment versus standard agonist treatment for opiate dependence Search methods We searched the Cochrane Drugs and Alcohol Group trials register (June 2011), Cochrane Central Register of Controlled Trials (CENTRAL) (Issue 6, 2011), PUBMED (1996 to 2011); EMBASE (January 1980 to 2011); CINAHL (January 2003 to 2011); PsycINFO (1985 to 2003) and reference list of articles. Selection criteria Randomised controlled trials and controlled clinical trial comparing any psychosocial plus any agonist with any agonist alone for opiate dependence. Data collection and analysis Two authors independently assessed trial quality quality and extracted data. Main results 35 studies, 4319 participants, were included. These studies considered thirteen different psychosocial interventions. Comparing any psychosocial plus any maintenance pharmacological treatment to standard maintenance treatment, results do not show benefit for retention in treatment, 27 studies, 3124 participants, RR 1.03 (95% CI 0.98 to 1.07), abstinence by opiate during the treatment, 8 studies, 1002 participants, RR 1.12 (95% CI 0.92 to 1.37), compliance, three studies, MD 0.43 (95% CI ‐0.05 to 0.92), psychiatric symptoms, 3 studies, MD 0.02 (‐0.28 to 0.31), depression, 3 studies, MD ‐1.70 (95% CI ‐3.91 to 0.51) and results at the end of follow up as number of participants still in treatment, 3 studies, 250 participants, RR 0.90 (95% CI 0.77 to 1.07) and participants abstinent by opioid, 3 studies, 181 participants, RR 1.15 (95% CI 0.98 to 1.36). Comparing the different psychosocial approaches, results are never statistically significant for all the comparisons and outcomes. Authors' conclusions For the considered outcomes, it seems that adding any psychosocial support to standard maintenance treatments do not add additional benefits. Data do not show differences also for contingency approaches, contrary to all expectations. Duration of the studies was too short to analyse relevant outcomes such as mortality. It should be noted that the control intervention used in the studies included in the review on maintenance treatments, is a program that routinely offers counselling sessions in addition to methadone; thus the review, actually, d
doi_str_mv 10.1002/14651858.CD004147.pub4
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_896827589</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>896827589</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4174-93541c4ba490977bed82aaa097bc55500736b7e1e06138c767de98d66d708a43</originalsourceid><addsrcrecordid>eNqFkctOwzAQRS0Eorx-AXnHqsVOHNtZQnlKSLBgbzn2lBoldrATqv4Bn02qtoDYdDWjmXPnSnMROqdkQgnJLinjBZWFnExvCGGUiUnbV2wPHa0W49Vm_08_QscpvROS8zITh2iU0VIUgmVH6OslLc08pGCcrrEJTeU8WLxw3Rzrt-Bd6nCjne_Aa28AdxF014DvEv6EmPq0i9J18IBnIf4OcZjh0LrgLLbQgrcwaE7RwUzXCc429QS93t2-Th_GT8_3j9Orp7FhVLBxmReMGlZpVpJSiAqszLTWQ1-ZoigIETmvBFAgnObSCC4slNJybgWRmuUn6GJ9to3ho4fUqcYlA3WtPYQ-KVlymYlClgPJ16SJIaUIM9VG1-i4VJSoVQZqm4HaZqBWGQzC841FXzVgf2Tbpw_A9RpYuBqWygQzj4P9jrv_XL4BV5uaew</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>896827589</pqid></control><display><type>article</type><title>Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Amato, Laura ; Minozzi, Silvia ; Davoli, Marina ; Vecchi, Simona ; Amato, Laura</creator><creatorcontrib>Amato, Laura ; Minozzi, Silvia ; Davoli, Marina ; Vecchi, Simona ; Amato, Laura</creatorcontrib><description>Background Maintenance treatments are effective in retaining patients in treatment and suppressing heroin use. Questions remain regarding the efficacy of additional psychosocial services. Objectives To evaluate the effectiveness of any psychosocial plus any agonist maintenance treatment versus standard agonist treatment for opiate dependence Search methods We searched the Cochrane Drugs and Alcohol Group trials register (June 2011), Cochrane Central Register of Controlled Trials (CENTRAL) (Issue 6, 2011), PUBMED (1996 to 2011); EMBASE (January 1980 to 2011); CINAHL (January 2003 to 2011); PsycINFO (1985 to 2003) and reference list of articles. Selection criteria Randomised controlled trials and controlled clinical trial comparing any psychosocial plus any agonist with any agonist alone for opiate dependence. Data collection and analysis Two authors independently assessed trial quality quality and extracted data. Main results 35 studies, 4319 participants, were included. These studies considered thirteen different psychosocial interventions. Comparing any psychosocial plus any maintenance pharmacological treatment to standard maintenance treatment, results do not show benefit for retention in treatment, 27 studies, 3124 participants, RR 1.03 (95% CI 0.98 to 1.07), abstinence by opiate during the treatment, 8 studies, 1002 participants, RR 1.12 (95% CI 0.92 to 1.37), compliance, three studies, MD 0.43 (95% CI ‐0.05 to 0.92), psychiatric symptoms, 3 studies, MD 0.02 (‐0.28 to 0.31), depression, 3 studies, MD ‐1.70 (95% CI ‐3.91 to 0.51) and results at the end of follow up as number of participants still in treatment, 3 studies, 250 participants, RR 0.90 (95% CI 0.77 to 1.07) and participants abstinent by opioid, 3 studies, 181 participants, RR 1.15 (95% CI 0.98 to 1.36). Comparing the different psychosocial approaches, results are never statistically significant for all the comparisons and outcomes. Authors' conclusions For the considered outcomes, it seems that adding any psychosocial support to standard maintenance treatments do not add additional benefits. Data do not show differences also for contingency approaches, contrary to all expectations. Duration of the studies was too short to analyse relevant outcomes such as mortality. It should be noted that the control intervention used in the studies included in the review on maintenance treatments, is a program that routinely offers counselling sessions in addition to methadone; thus the review, actually, did not evaluate the question of whether any ancillary psychosocial intervention is needed when methadone maintenance is provided, but the narrower question of whether a specific more structured intervention provides any additional benefit to a standard psychosocial support. These interventions probably can be measured and evaluated by employing diverse criteria for evaluating treatment outcomes, aimed to rigorously assess changes in emotional, interpersonal, vocational and physical health areas of life functioning.</description><identifier>ISSN: 1465-1858</identifier><identifier>EISSN: 1465-1858</identifier><identifier>EISSN: 1469-493X</identifier><identifier>DOI: 10.1002/14651858.CD004147.pub4</identifier><identifier>PMID: 21975742</identifier><language>eng</language><publisher>Chichester, UK: John Wiley &amp; Sons, Ltd</publisher><subject>Combined Modality Therapy ; Combined Modality Therapy - methods ; Humans ; Medicine General &amp; Introductory Medical Sciences ; Narcotics ; Narcotics - therapeutic use ; Opioid-Related Disorders - psychology ; Opioid-Related Disorders - rehabilitation ; Opioids abuse and dependence ; Opioids, opiates, heroin ; Opioid‐Related Disorders ; Psychosocial interventions ; Psychotherapy ; Psychotherapy - methods ; Randomized Controlled Trials as Topic ; Tobacco, drugs &amp; alcohol</subject><ispartof>Cochrane database of systematic reviews, 2011-10, Vol.2011 (10), p.CD004147-CD004147</ispartof><rights>Copyright © 2011 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4174-93541c4ba490977bed82aaa097bc55500736b7e1e06138c767de98d66d708a43</citedby><cites>FETCH-LOGICAL-c4174-93541c4ba490977bed82aaa097bc55500736b7e1e06138c767de98d66d708a43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21975742$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Amato, Laura</creatorcontrib><creatorcontrib>Minozzi, Silvia</creatorcontrib><creatorcontrib>Davoli, Marina</creatorcontrib><creatorcontrib>Vecchi, Simona</creatorcontrib><creatorcontrib>Amato, Laura</creatorcontrib><title>Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence</title><title>Cochrane database of systematic reviews</title><addtitle>Cochrane Database Syst Rev</addtitle><description>Background Maintenance treatments are effective in retaining patients in treatment and suppressing heroin use. Questions remain regarding the efficacy of additional psychosocial services. Objectives To evaluate the effectiveness of any psychosocial plus any agonist maintenance treatment versus standard agonist treatment for opiate dependence Search methods We searched the Cochrane Drugs and Alcohol Group trials register (June 2011), Cochrane Central Register of Controlled Trials (CENTRAL) (Issue 6, 2011), PUBMED (1996 to 2011); EMBASE (January 1980 to 2011); CINAHL (January 2003 to 2011); PsycINFO (1985 to 2003) and reference list of articles. Selection criteria Randomised controlled trials and controlled clinical trial comparing any psychosocial plus any agonist with any agonist alone for opiate dependence. Data collection and analysis Two authors independently assessed trial quality quality and extracted data. Main results 35 studies, 4319 participants, were included. These studies considered thirteen different psychosocial interventions. Comparing any psychosocial plus any maintenance pharmacological treatment to standard maintenance treatment, results do not show benefit for retention in treatment, 27 studies, 3124 participants, RR 1.03 (95% CI 0.98 to 1.07), abstinence by opiate during the treatment, 8 studies, 1002 participants, RR 1.12 (95% CI 0.92 to 1.37), compliance, three studies, MD 0.43 (95% CI ‐0.05 to 0.92), psychiatric symptoms, 3 studies, MD 0.02 (‐0.28 to 0.31), depression, 3 studies, MD ‐1.70 (95% CI ‐3.91 to 0.51) and results at the end of follow up as number of participants still in treatment, 3 studies, 250 participants, RR 0.90 (95% CI 0.77 to 1.07) and participants abstinent by opioid, 3 studies, 181 participants, RR 1.15 (95% CI 0.98 to 1.36). Comparing the different psychosocial approaches, results are never statistically significant for all the comparisons and outcomes. Authors' conclusions For the considered outcomes, it seems that adding any psychosocial support to standard maintenance treatments do not add additional benefits. Data do not show differences also for contingency approaches, contrary to all expectations. Duration of the studies was too short to analyse relevant outcomes such as mortality. It should be noted that the control intervention used in the studies included in the review on maintenance treatments, is a program that routinely offers counselling sessions in addition to methadone; thus the review, actually, did not evaluate the question of whether any ancillary psychosocial intervention is needed when methadone maintenance is provided, but the narrower question of whether a specific more structured intervention provides any additional benefit to a standard psychosocial support. These interventions probably can be measured and evaluated by employing diverse criteria for evaluating treatment outcomes, aimed to rigorously assess changes in emotional, interpersonal, vocational and physical health areas of life functioning.</description><subject>Combined Modality Therapy</subject><subject>Combined Modality Therapy - methods</subject><subject>Humans</subject><subject>Medicine General &amp; Introductory Medical Sciences</subject><subject>Narcotics</subject><subject>Narcotics - therapeutic use</subject><subject>Opioid-Related Disorders - psychology</subject><subject>Opioid-Related Disorders - rehabilitation</subject><subject>Opioids abuse and dependence</subject><subject>Opioids, opiates, heroin</subject><subject>Opioid‐Related Disorders</subject><subject>Psychosocial interventions</subject><subject>Psychotherapy</subject><subject>Psychotherapy - methods</subject><subject>Randomized Controlled Trials as Topic</subject><subject>Tobacco, drugs &amp; alcohol</subject><issn>1465-1858</issn><issn>1465-1858</issn><issn>1469-493X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>RWY</sourceid><sourceid>EIF</sourceid><recordid>eNqFkctOwzAQRS0Eorx-AXnHqsVOHNtZQnlKSLBgbzn2lBoldrATqv4Bn02qtoDYdDWjmXPnSnMROqdkQgnJLinjBZWFnExvCGGUiUnbV2wPHa0W49Vm_08_QscpvROS8zITh2iU0VIUgmVH6OslLc08pGCcrrEJTeU8WLxw3Rzrt-Bd6nCjne_Aa28AdxF014DvEv6EmPq0i9J18IBnIf4OcZjh0LrgLLbQgrcwaE7RwUzXCc429QS93t2-Th_GT8_3j9Orp7FhVLBxmReMGlZpVpJSiAqszLTWQ1-ZoigIETmvBFAgnObSCC4slNJybgWRmuUn6GJ9to3ho4fUqcYlA3WtPYQ-KVlymYlClgPJ16SJIaUIM9VG1-i4VJSoVQZqm4HaZqBWGQzC841FXzVgf2Tbpw_A9RpYuBqWygQzj4P9jrv_XL4BV5uaew</recordid><startdate>20111005</startdate><enddate>20111005</enddate><creator>Amato, Laura</creator><creator>Minozzi, Silvia</creator><creator>Davoli, Marina</creator><creator>Vecchi, Simona</creator><creator>Amato, Laura</creator><general>John Wiley &amp; Sons, Ltd</general><scope>7PX</scope><scope>RWY</scope><scope>ZYTZH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20111005</creationdate><title>Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence</title><author>Amato, Laura ; Minozzi, Silvia ; Davoli, Marina ; Vecchi, Simona ; Amato, Laura</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4174-93541c4ba490977bed82aaa097bc55500736b7e1e06138c767de98d66d708a43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Combined Modality Therapy</topic><topic>Combined Modality Therapy - methods</topic><topic>Humans</topic><topic>Medicine General &amp; Introductory Medical Sciences</topic><topic>Narcotics</topic><topic>Narcotics - therapeutic use</topic><topic>Opioid-Related Disorders - psychology</topic><topic>Opioid-Related Disorders - rehabilitation</topic><topic>Opioids abuse and dependence</topic><topic>Opioids, opiates, heroin</topic><topic>Opioid‐Related Disorders</topic><topic>Psychosocial interventions</topic><topic>Psychotherapy</topic><topic>Psychotherapy - methods</topic><topic>Randomized Controlled Trials as Topic</topic><topic>Tobacco, drugs &amp; alcohol</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Amato, Laura</creatorcontrib><creatorcontrib>Minozzi, Silvia</creatorcontrib><creatorcontrib>Davoli, Marina</creatorcontrib><creatorcontrib>Vecchi, Simona</creatorcontrib><creatorcontrib>Amato, Laura</creatorcontrib><collection>Wiley-Blackwell Cochrane Library</collection><collection>Cochrane Library</collection><collection>Cochrane Library (Open Aceess)</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cochrane database of systematic reviews</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Amato, Laura</au><au>Minozzi, Silvia</au><au>Davoli, Marina</au><au>Vecchi, Simona</au><au>Amato, Laura</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence</atitle><jtitle>Cochrane database of systematic reviews</jtitle><addtitle>Cochrane Database Syst Rev</addtitle><date>2011-10-05</date><risdate>2011</risdate><volume>2011</volume><issue>10</issue><spage>CD004147</spage><epage>CD004147</epage><pages>CD004147-CD004147</pages><issn>1465-1858</issn><eissn>1465-1858</eissn><eissn>1469-493X</eissn><abstract>Background Maintenance treatments are effective in retaining patients in treatment and suppressing heroin use. Questions remain regarding the efficacy of additional psychosocial services. Objectives To evaluate the effectiveness of any psychosocial plus any agonist maintenance treatment versus standard agonist treatment for opiate dependence Search methods We searched the Cochrane Drugs and Alcohol Group trials register (June 2011), Cochrane Central Register of Controlled Trials (CENTRAL) (Issue 6, 2011), PUBMED (1996 to 2011); EMBASE (January 1980 to 2011); CINAHL (January 2003 to 2011); PsycINFO (1985 to 2003) and reference list of articles. Selection criteria Randomised controlled trials and controlled clinical trial comparing any psychosocial plus any agonist with any agonist alone for opiate dependence. Data collection and analysis Two authors independently assessed trial quality quality and extracted data. Main results 35 studies, 4319 participants, were included. These studies considered thirteen different psychosocial interventions. Comparing any psychosocial plus any maintenance pharmacological treatment to standard maintenance treatment, results do not show benefit for retention in treatment, 27 studies, 3124 participants, RR 1.03 (95% CI 0.98 to 1.07), abstinence by opiate during the treatment, 8 studies, 1002 participants, RR 1.12 (95% CI 0.92 to 1.37), compliance, three studies, MD 0.43 (95% CI ‐0.05 to 0.92), psychiatric symptoms, 3 studies, MD 0.02 (‐0.28 to 0.31), depression, 3 studies, MD ‐1.70 (95% CI ‐3.91 to 0.51) and results at the end of follow up as number of participants still in treatment, 3 studies, 250 participants, RR 0.90 (95% CI 0.77 to 1.07) and participants abstinent by opioid, 3 studies, 181 participants, RR 1.15 (95% CI 0.98 to 1.36). Comparing the different psychosocial approaches, results are never statistically significant for all the comparisons and outcomes. Authors' conclusions For the considered outcomes, it seems that adding any psychosocial support to standard maintenance treatments do not add additional benefits. Data do not show differences also for contingency approaches, contrary to all expectations. Duration of the studies was too short to analyse relevant outcomes such as mortality. It should be noted that the control intervention used in the studies included in the review on maintenance treatments, is a program that routinely offers counselling sessions in addition to methadone; thus the review, actually, did not evaluate the question of whether any ancillary psychosocial intervention is needed when methadone maintenance is provided, but the narrower question of whether a specific more structured intervention provides any additional benefit to a standard psychosocial support. These interventions probably can be measured and evaluated by employing diverse criteria for evaluating treatment outcomes, aimed to rigorously assess changes in emotional, interpersonal, vocational and physical health areas of life functioning.</abstract><cop>Chichester, UK</cop><pub>John Wiley &amp; Sons, Ltd</pub><pmid>21975742</pmid><doi>10.1002/14651858.CD004147.pub4</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1465-1858
ispartof Cochrane database of systematic reviews, 2011-10, Vol.2011 (10), p.CD004147-CD004147
issn 1465-1858
1465-1858
1469-493X
language eng
recordid cdi_proquest_miscellaneous_896827589
source MEDLINE; Alma/SFX Local Collection
subjects Combined Modality Therapy
Combined Modality Therapy - methods
Humans
Medicine General & Introductory Medical Sciences
Narcotics
Narcotics - therapeutic use
Opioid-Related Disorders - psychology
Opioid-Related Disorders - rehabilitation
Opioids abuse and dependence
Opioids, opiates, heroin
Opioid‐Related Disorders
Psychosocial interventions
Psychotherapy
Psychotherapy - methods
Randomized Controlled Trials as Topic
Tobacco, drugs & alcohol
title Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T09%3A30%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Psychosocial%20combined%20with%20agonist%20maintenance%20treatments%20versus%20agonist%20maintenance%20treatments%20alone%20for%20treatment%20of%20opioid%20dependence&rft.jtitle=Cochrane%20database%20of%20systematic%20reviews&rft.au=Amato,%20Laura&rft.date=2011-10-05&rft.volume=2011&rft.issue=10&rft.spage=CD004147&rft.epage=CD004147&rft.pages=CD004147-CD004147&rft.issn=1465-1858&rft.eissn=1465-1858&rft_id=info:doi/10.1002/14651858.CD004147.pub4&rft_dat=%3Cproquest_cross%3E896827589%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=896827589&rft_id=info:pmid/21975742&rfr_iscdi=true